Effects on the liver: Non-malignant effects:
NOLVADEX has been associated with changes in liver enzyme levels, and on rare occasions, a
spectrum of more severe liver abnormalities including fatty liver, cholestasis, hepatitis and
hepatic necrosis. A few of these serious cases included fatalities. In most reported cases the
relationship to NOLVADEX is uncertain. However, some positive rechallenges and
dechallenges have been reported.
In the NSABP P-1 trial, few grade 3-4 changes in liver function (SGOT, SGPT, bilirubin,
alkaline phosphatase) were observed.
Also, Nolvadex has been shown to lower IGF-1 levels which is tough on a PCT cycle. I just think the OVERUSE of Nolvadex is the problem.
What do you guys think?
NOLVADEX has been associated with changes in liver enzyme levels, and on rare occasions, a
spectrum of more severe liver abnormalities including fatty liver, cholestasis, hepatitis and
hepatic necrosis. A few of these serious cases included fatalities. In most reported cases the
relationship to NOLVADEX is uncertain. However, some positive rechallenges and
dechallenges have been reported.
In the NSABP P-1 trial, few grade 3-4 changes in liver function (SGOT, SGPT, bilirubin,
alkaline phosphatase) were observed.
Also, Nolvadex has been shown to lower IGF-1 levels which is tough on a PCT cycle. I just think the OVERUSE of Nolvadex is the problem.
What do you guys think?